#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Duchenne muscular dystrophy gene carrier Neuroblastoma recurrent Urea cycle disorder Pleomorphic leiomyosarcoma Hereditary hypophosphataemic rickets Loss of consciousness Noonan syndrome Alveolar rhabdomyosarcoma Biliary neoplasm KBG syndrome Ataxia telangiectasia Cardiac arrest Proteus syndrome Vitamin B12 deficiency B-cell small lymphocytic lymphoma refractory More trials…

    Learn about Rare Diseases

    Bronchiolitis obliterans syndrome – Basic Information Choroid melanoma – Life with Disease Lymphatic malformation – Life with Disease Hereditary angioedema with C1 esterase inhibitor deficiency – Basic Information IgA nephropathy – Trials in Disease Aicardi-Goutieres syndrome – Basic Information Alveolar rhabdomyosarcoma – Diagnostics Biotinidase deficiency Leiomyosarcoma recurrent – Treatment Ornithine transcarbamoylase deficiency – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    ARLOCABTAGENE AUTOLEUCEL Ribitol OMECAMTIV MECARBIL Midazolam Zinc Acetate Dihydrate Moxifloxacin Itacitinib Lenvatinib Domperidone Festuca Elatior Pollen Extract Pravastatin Sodium IPN01195 Gsk4381562A Lomustine ABY-271 Procarbazine Lumasiran Mps-103 Streptococcus Agalactiae Daptomycin More therapies…

    Learn about Your Condition

    Proteus syndrome Lichenoid keratosis Immunodeficiency congenital Hot flush Drug dependence Herpes zoster Hyperphagia Exfoliation glaucoma Haemorrhoids Schizophreniform disorder Hepatorenal syndrome Usher's syndrome Status epilepticus Paraganglion neoplasm Anal squamous cell carcinoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Asthma

  • Study on Glycopyrronium Bromide for Children Aged 6-12 with Asthma

    Recruiting

    2 1 1
    Investigated Drugs:
    • Salmeterol Xinafoate
    • Fluticasone Propionate
    • Salbutamol
    Bulgaria Hungary Poland Spain

  • Study on Extending Dosing Intervals of Mepolizumab and Dupilumab for Patients with Severe Asthma

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • Mepolizumab
    • Dupilumab
    The Netherlands

  • Study on Tezepelumab for Children Aged 5 to 11 with Severe Asthma

    Recruiting

    3 1 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • Tezepelumab
    France Hungary Italy The Netherlands Poland Romania +1

  • Study on the Effectiveness and Safety of Indacaterol Acetate/Mometasone Furoate vs. Budesonide for Children Aged 6-11 with Asthma

    Recruiting

    3 1 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • Indacaterol Acetate
    • Fluticasone Propionate
    • Salbutamol
    Austria Bulgaria Czechia Greece Hungary Italy +3

  • Study on Salbutamol and Ipratropium Bromide for Treating Moderate Asthma Attacks in Children

    Recruiting

    3 1 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • Ipratropium Bromide Monohydrate
    Spain

  • Study on Azithromycin for Treating Hospitalized Children Aged 1-5 with Asthma Symptoms

    Recruiting

    2 1 1
    Investigated Diseases:
    • Childhood asthma
    • Asthma
    Investigated Drugs:
    • Azithromycin
    • Hydroxypropyl Cellulose Lf
    • Sodium Phosphate Dodecahydrate
    Denmark
Previous Page
1 2 3 4 5 6 … 14
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!